Marcus Plescia, MD, MPH
A survey of medical cannabis users in Minnesota shows 4 in 10 feel the drug has given them significant pain reduction.
The data are based on self-evaluations by 2174 patients enrolled in the state’s medical cannabis program during the last 5 months of 2016. Those patients were required to complete a pain, enjoyment, general activity (PEG) assessment on a scale of 1 to 10 prior to each purchase.
Those self-reports showed 42% of patients had pain reductions of more 30% or more. Nearly one-quarter of participants maintained the 30%-or-more pain-reduction threshold over the course of the study. Fifty-five patients reported severe adverse effects (sAEs).
Tom Arneson, MD, MPH, the research manager for the Minnesota Department of Health’s Office of Medical Cannabis, said the study is part of the state’s ongoing evaluation of its program. He said it is important not to overemphasize the results